Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Shamash

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
European Urology Oncology|November 5, 2024
Management of Small Testicular Masses: A Delphi Consensus StudyKarl H Pang, Giuseppe Fallara, João Lobo, et al.
British Journal of Cancer|September 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update databaseJakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, et al.
JNCI Cancer Spectrum|November 22, 2019
Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration RateEdward H Williams, Claire M Connell, James M J Weaver, et al.
BMJ Open|September 3, 2020
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesotheliomaEric Lim, Liz Darlison, John Edwards, et al.
JAMA Oncology|September 2, 2016
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical TrialPeter W Szlosarek, Jeremy P Steele, Luke Nolan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update ConsortiumSilke Gillessen, Nicolas Sauvé, Laurence Collette, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update ConsortiumEmanuel Bührer, David D'Haese, Gedske Daugaard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update ConsortiumJörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2022
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)Johnathan K Joffe, Fay H Cafferty, Laura Murphy, et al.
The Lancet. Respiratory Medicine|May 13, 2024
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trialEric Lim, David Waller, Kelvin Lau, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
European Urology Oncology|November 5, 2024
Management of Small Testicular Masses: A Delphi Consensus StudyKarl H Pang, Giuseppe Fallara, João Lobo, et al.
British Journal of Cancer|September 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update databaseJakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, et al.
JNCI Cancer Spectrum|November 22, 2019
Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration RateEdward H Williams, Claire M Connell, James M J Weaver, et al.
BMJ Open|September 3, 2020
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesotheliomaEric Lim, Liz Darlison, John Edwards, et al.
JAMA Oncology|September 2, 2016
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical TrialPeter W Szlosarek, Jeremy P Steele, Luke Nolan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update ConsortiumSilke Gillessen, Nicolas Sauvé, Laurence Collette, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update ConsortiumEmanuel Bührer, David D'Haese, Gedske Daugaard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update ConsortiumJörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2022
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)Johnathan K Joffe, Fay H Cafferty, Laura Murphy, et al.
The Lancet. Respiratory Medicine|May 13, 2024
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trialEric Lim, David Waller, Kelvin Lau, et al.
Pageof 11